Armata Pharmaceuticals, Inc.ARMPNYSE

Revenue (LTM)

$5M

+14.2% YoY

Net Income (LTM)

$-19M

+72.6% YoY

Free Cash Flow

$-39M

Revenue CAGR (5Y)

+58.3%

Marginsimproving

FCF($0.0B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	1	4↑443.6%	6↑23.1%	5↓17.8%	5↑14.2%
Gross Profit	-14	-16↓14.1%	-30↓89.9%	4↑112.1%	-29↓922.4%
Operating Income	-22	-24↓10.4%	-37↓55.1%	-41↓10.7%	-42↓3.8%
Net Income	-22	-23↓4.4%	-37↓59.4%	-69↓87.0%	-19↑72.6%
EBITDA	-20	-22↓7.3%	-36↓64.5%	-65↓81.5%	-41↑37.2%
EPS Diluted	-1.35	-0.96↑28.9%	-1.08↓12.5%	-1.91↓76.9%	-0.52↑72.6%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	10	10↑6.6%	15↑44.4%	14↓8.9%	9↓31.3%
Total Current Assets	11	15↑38.3%	27↑80.4%	19↓29.2%	11↓41.0%
Total Assets	40	70↑76.6%	108↑54.6%	98↓8.8%	86↓12.1%
Total Current Liabilities	7	5↓28.2%	25↑416.7%	16↓33.8%	48↑193.1%
Total Liabilities	21	44↑114.8%	72↑61.8%	130↑81.7%	134↑3.1%
Total Equity	19	25↑34.7%	36↑42.1%	-32↓188.9%	-48↓49.8%
Total Debt	13	38↑188.9%	49↑28.5%	120↑146.6%	127↑5.1%
Net Debt	4	28↑691.2%	34↑22.6%	107↑214.6%	117↑9.7%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-18	-24↓29.0%	-32↓37.8%	-47↓46.0%	-38↑20.8%
Capital Expenditure	-1	-1↓58.3%	-2↓69.6%	-8↓268.3%	-2↑76.9%
Free Cash Flow	-19	-25↓30.3%	-35↓39.4%	-56↓60.2%	-39↑29.0%
Stock-Based Comp	3	3↓17.1%	3↑7.7%	1↓69.8%	3↑208.4%
Net Change in Cash	4	1↓84.5%	5↑614.2%	-2↓134.4%	-4↓185.0%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance